Pharmacokinetics and safety of cenobamate, a novel antiseizure medication, in healthy Japanese, and an ethnic comparison with healthy non-Japanese.

MLA

Yang, Eunsol, et al. “Pharmacokinetics and Safety of Cenobamate, a Novel Antiseizure Medication, in Healthy Japanese, and an Ethnic Comparison with Healthy Non-Japanese.” Clinical and Translational Science, vol. 15, no. 2, Feb. 2022, pp. 490–500. EBSCOhost, https://doi.org/10.1111/cts.13167.

APA

Yang, E., Sunwoo, J., Huh, K. Y., Kim, Y. K., Lee, S., Jang, I.-J., & Yu, K.-S. (2022). Pharmacokinetics and safety of cenobamate, a novel antiseizure medication, in healthy Japanese, and an ethnic comparison with healthy non-Japanese. Clinical and Translational Science, 15(2), 490–500. https://doi.org/10.1111/cts.13167

Chicago

Yang, Eunsol, Jung Sunwoo, Ki Young Huh, Yu Kyong Kim, SeungHwan Lee, In-Jin Jang, and Kyung-Sang Yu. 2022. “Pharmacokinetics and Safety of Cenobamate, a Novel Antiseizure Medication, in Healthy Japanese, and an Ethnic Comparison with Healthy Non-Japanese.” Clinical and Translational Science 15 (2): 490–500. doi:10.1111/cts.13167.